Atlas Trials

Treatment of High Risk Myelodysplastic Syndromes (MDS) Not Candidates for Allogeneic Transplantation of Hematopoietic Progenitors (ALO-HSCT)

Clinical trial NCT04602273 · UNKNOWN

Trial details

NCT number
NCT04602273
Sponsor
Grupo Cooperativo de Estudio y Tratamiento de las Leucemias Agudas y Mielodisplasias
Status
UNKNOWN
Study type
OBSERVATIONAL
Myelodysplastic Syndromes
Start date
2016-12-12
Primary completion
2020-11-01
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.